LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown.

    Anjana, Ranjit Mohan / Pradeepa, Rajendra / Deepa, Mohan / Jebarani, Saravanan / Venkatesan, Ulagamathesan / Parvathi, Somasundaram Jaya / Balasubramanyam, Muthuswamy / Radha, Venkatesan / Poongothai, Subramani / Sudha, Vasudevan / Shanthi Rani, Coimbatore Subramanian / Ranjani, Harish / Amutha, Anandakumar / Manickam, Nagaraj / Unnikrishnan, Ranjit / Mohan, Viswanathan

    Diabetes technology & therapeutics

    2020  Volume 22, Issue 7, Page(s) 527–534

    Abstract: Aim: ...

    Abstract Aim:
    MeSH term(s) Adult ; Betacoronavirus ; Blood Glucose/analysis ; Blood Glucose Self-Monitoring/statistics & numerical data ; COVID-19 ; Coronavirus Infections/prevention & control ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/psychology ; Diabetes Mellitus, Type 2/therapy ; Female ; Humans ; India/epidemiology ; Male ; Middle Aged ; Pandemics/prevention & control ; Patient Acceptance of Health Care/statistics & numerical data ; Patient Satisfaction/statistics & numerical data ; Pneumonia, Viral/prevention & control ; Quarantine/psychology ; Quarantine/statistics & numerical data ; SARS-CoV-2 ; Telemedicine/methods ; Telemedicine/statistics & numerical data
    Chemical Substances Blood Glucose
    Keywords covid19
    Language English
    Publishing date 2020-06-22
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 1452816-2
    ISSN 1557-8593 ; 1520-9156
    ISSN (online) 1557-8593
    ISSN 1520-9156
    DOI 10.1089/dia.2020.0240
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 5269: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article: Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown

    Anjana, Ranjit Mohan / Pradeepa, Rajendra / Deepa, Mohan / Jebarani, Saravanan / Venkatesan, Ulagamathesan / Parvathi, Somasundaram Jaya / Balasubramanyam, Muthuswamy / Radha, Venkatesan / Poongothai, Subramani / Sudha, Vasudevan / Shanthi Rani, Coimbatore Subramanian / Ranjani, Harish / Amutha, Anandakumar / Manickam, Nagaraj / Unnikrishnan, Ranjit / Mohan, Viswanathan

    Diabetes Technol Ther

    Abstract: ... of newer technologies and changes in glycemic control on patients with type 2 diabetes (T2D) in India ... in glycemic control during the lockdown (HbA1c:before vs. during lockdown: 8.2% ± 1.9% vs. 7.7% ± 1.7%, P < 0 ... challenges to diabetes care and use of technologies such as telemedicine facilities and use ...

    Abstract Aim: To evaluate the effects of a prolonged lockdown due to Coronavirus (COVID-19) on the adoption of newer technologies and changes in glycemic control on patients with type 2 diabetes (T2D) in India. Methods: The study population included a random list of 3000 individuals with T2D derived from 30,748 individuals who had visited a large tertiary diabetes center during the past year. The survey was carried out through a telephonic interview. A structured questionnaire was used to collect information on changes in lifestyle, access and challenges to diabetes care and use of technologies such as telemedicine facilities and use of self-monitoring of blood glucose (SMBG), etc. Results: Of the 2510 individuals successfully interviewed (83.7% response rate), 382 (15.2%) reported having attempted to consult their health care providers during the lockdown, of whom only 30.6% utilized the telemedicine facility. However, 96 (82%) of those who utilized the telemedicine facility (n = 117) were happy with their experience and 68 (58.1%) were willing to continue to use the facility in the future. Only 11.4% of participants utilized online support for management of diabetes. Use of SMBG increased significantly from 15.5% to 51.3% during the lockdown. There was an improvement in glycemic control during the lockdown (HbA1c:before vs. during lockdown: 8.2% ± 1.9% vs. 7.7% ± 1.7%, P < 0.001) in a nonrandomly selected subset of subjects (n = 205). Conclusions: Acceptance of telemedicine facilities remains suboptimal in this Asian Indian population, in spite of high levels of satisfaction among those who utilized it. The COVID-19 pandemic and the subsequent lockdown have not adversely affected metabolic control in our patients, and indeed there appears to be an improvement in HbA1c levels. Greater accessibility and acceptance of technology could help individuals with diabetes to maintain better contact with their physicians and ensure better metabolic control in the future.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #597020
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top